Clinical Trial Update: Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intrathecal administration of expanded Wharton's Jelly mesenchymal stem cells in chronic traumatic spinal cord injury has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury
• Spinal Cord Injury Chronic

Drugs mentioned

• Wharton's Jelly mesenchymal stem cells (expanded) (mesenchymal stem cells)

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Spinal Cord Injury, Chronic | Phase 1, Phase 2 | Status: COMPLETED